Inflamax Research Announces Positive Results of a Phase IIa Allergic...

Positive results from a single-centre, double-masked, randomized, vehicle-controlled Phase IIa study in allergic conjunctivitis patients treated with NS2 ophthalmic solution from Aldeyra Therapeutics,...(PRWeb March 03, 2016)Read the full story at http://www.prweb.com/releases/2016/03/prweb13245384.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news